Professor of Pediatrics and Chief of Endocrinology, HSE 1427, University of California, San Francisco, San Francisco, California 94143-0978, USA.
Endocrinology. 2010 Apr;151(4):1677-84. doi: 10.1210/en.2009-1247. Epub 2010 Feb 16.
Cytochrome P450c17 (P450c17) is the single microsomal enzyme that catalyzes steroid 17alpha-hydroxylase and 17,20 lyase activities. The ratio of lyase to hydroxylase activity of human P450c17 determines whether steroidogenesis leads to the synthesis of cortisol or sex steroids. This ratio is regulated posttranslationally by factors that influence the efficiency of electron transfer from P450 oxidoreductase to P450c17. One factor favoring more efficient electron transfer and 17,20 lyase activity is cAMP-dependent serine/threonine phosphorylation of P450c17. Identifying the responsible kinase(s) and the P450c17 residues that undergo phosphorylation has been challenging, partly because of difficulties in preparing biochemically useful amounts of pure, catalytically active P450c17. We describe a modified strategy for preparing P450c17 in which the traditional carboxy-terminal 4xHis tag is replaced by 3xGly6xHis. This construct permits more rotational freedom of the protein when bound to the nickel affinity column, reducing steric associations between the protein and the column, and permitting a single-step chromatographic purification to apparent homogeneity. Using this vector, we explored P450c17 phosphorylation by mutagenesis of Ser and/or Thr residues to Asp or Glu to mimic the approximate size and charge of phospho-Ser or phospho-Thr. This strategy did not identify Ser and/or Thr site(s) that increase the ratio of lyase to hydroxylase activity, suggesting that the regulatory phosphorylation strategy of human P450c17 is very complicated. Although previous work has excluded protein kinase A (PKA) as the responsible kinase, the cAMP-inducible nature of the phosphorylation-associated increase in lyase activity suggests that PKA may play a role, possibly as a priming kinase. Using our novel vector and a series of mutations, we identified the P450c17 site phosphorylated by PKA as Ser258.
细胞色素 P450c17(P450c17)是唯一一种催化甾体 17α-羟化酶和 17,20 裂解酶活性的微粒体酶。人 P450c17 的裂解酶与羟化酶活性之比决定了甾体生成是否导致皮质醇或性激素的合成。这种比率受影响 P450 氧化还原酶向 P450c17 电子转移效率的因素进行翻译后调节。有利于更有效的电子转移和 17,20 裂解酶活性的一个因素是 cAMP 依赖性丝氨酸/苏氨酸磷酸化 P450c17。鉴定负责的激酶(s)和经历磷酸化的 P450c17 残基一直具有挑战性,部分原因是难以制备具有生物化学用途的大量纯、催化活性 P450c17。我们描述了一种改良的制备 P450c17 的策略,其中传统的羧基末端 4xHis 标签被 3xGly6xHis 取代。与镍亲和柱结合时,该构建体允许蛋白质有更多的旋转自由度,减少蛋白质与柱之间的空间关联,并允许通过单一步骤色谱纯化至明显的均一性。使用该载体,我们通过将丝氨酸和/或苏氨酸残基突变为天冬氨酸或谷氨酸来模拟磷酸化丝氨酸或磷酸化苏氨酸的大致大小和电荷,来探索 P450c17 的磷酸化。该策略未鉴定出增加裂解酶与羟化酶活性之比的 Ser 和/或 Thr 位点,这表明人 P450c17 的调节性磷酸化策略非常复杂。尽管先前的工作排除了蛋白激酶 A(PKA)作为负责的激酶,但磷酸化相关裂解酶活性的 cAMP 诱导性质表明 PKA 可能发挥作用,可能作为启动激酶。使用我们的新型载体和一系列突变,我们鉴定了 PKA 磷酸化的 P450c17 位点为 Ser258。